Evidence map›Paper›PMID 32218301›Full record

ArticleMolecules (Basel, Switzerland)2020

Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses.

Valeria Francesconi, Elena Cichero, Silvia Schenone, Lieve Naesens, Michele Tonelli

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Recent Advances in Nitrogen-Containing Heterocyclic Scaffolds as Antiviral Agents.Medicinal chemistry (Shariqah (United Arab Emirates)) · 2024
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Promising Schiff bases in antiviral drug design and discovery.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2023
    Review
  13. Synthesis of NovelMolecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Valeria FrancesconiDipartimento di Farmacia, Università di Genova, Viale Benedetto XV 3, 16132 Genova, Italy.
Elena CicheroDipartimento di Farmacia, Università di Genova, Viale Benedetto XV 3, 16132 Genova, Italy.
Silvia SchenoneDipartimento di Farmacia, Università di Genova, Viale Benedetto XV 3, 16132 Genova, Italy.
Lieve NaesensRega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.ORCID 0000-0001-9742-9302
Michele TonelliDipartimento di Farmacia, Università di Genova, Viale Benedetto XV 3, 16132 Genova, Italy.ORCID 0000-0003-1518-2890
University of Genoa · ITRega Institute for Medical Research · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory RNA viruses are responsible for recurrent acute respiratory illnesses that still represent a major medical need. Previously we developed a large variety of benzimidazole derivatives able to inhibit these viruses. Herein, two series of (thio)semicarbazone- and hydrazone-based benzimidazoles have been explored, by derivatizing 5-acetyl benzimidazoles previously reported by us, thereby evaluating the influence of the modification on the antiviral activity. Compounds

Indexed as

AnimalsAntiviral AgentsBenzimidazolesCells, CulturedCoronavirusDogsHumansInfluenza A virusMadin Darby Canine Kidney CellsMicrobial Sensitivity TestsModels, MolecularRespiratory Syncytial Virus, HumanRespiratory Tract InfectionsSemicarbazonesStructure-Activity RelationshipAntiviral AgentsBenzimidazolesSemicarbazonesanti-coronavirus activityanti-influenza activityanti-RSV activityhydrazone-based benzimidazolesmolecular modelling studies(thio)semicarbazone-based benzimidazoles

Identifiers

PMID32218301
PMCPMC7180491
OpenAlexW3013153682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.